Voclosporin Induces Systemic Lipidomic Alterations: Implications for Lupus Nephritis Remission

Kidney Int Rep. 2024 May 9;9(8):2559-2562. doi: 10.1016/j.ekir.2024.04.069. eCollection 2024 Aug.
No abstract available

Keywords: cardiovascular risk; lipidomics; lupus nephritis; mediation analysis; remission; voclosporin.